Literature DB >> 26385521

Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.

Jennifer D Hood1, Veronika I Zarnitsyna2, Cheng Zhu3, Brian D Evavold4.   

Abstract

Having regulatory T cells (Tregs) with the same Ag specificity as the responding conventional T cells is thought to be important in maintaining peripheral tolerance. It has been demonstrated that during experimental autoimmune encephalomyelitis there are myelin oligodendrocyte glycoprotein (MOG)--specific Tregs that infiltrate into the CNS. However, the affinity of naturally occurring polyclonal Tregs for any self-antigen, let alone MOG, has not been analyzed in the periphery or at the site of autoimmune disease. Utilizing the highly sensitive micropipette adhesion frequency assay, which allows one to determine on a single-cell basis the affinity and frequency of polyclonal Ag-specific T cells directly ex vivo, we demonstrate that at peak disease MOG-specific Tregs were progressively enriched in the draining cervical lymph nodes and CNS as compared with spleen. These frequencies were greater than the frequencies measured by tetramer analysis, indicative of the large fraction of lower affinity T cells that comprise the MOG-specific conventional T cell (Tconv) and Treg response. Of interest, the self-reactive CD4(+) Tconvs and Tregs displayed overlapping affinities for MOG in the periphery, yet in the CNS, the site of neuroinflammation, Tconvs skew toward higher affinities. Most of the MOG-specific Tregs in the CNS possessed the methylation signature associated with thymic-derived Tregs. These findings indicate that thymic-derived Treg affinity range matches that of their Tconvs in the periphery and suggest a change in TCR affinity as a potential mechanism for autoimmune progression and escape from immune regulation.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26385521      PMCID: PMC4610855          DOI: 10.4049/jimmunol.1501464

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Autoreactive T cells in healthy individuals.

Authors:  Nancy A Danke; David M Koelle; Cassian Yee; Sucheta Beheray; William W Kwok
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

2.  Glutamine- and phosphate-containing hypotonic storage media better maintain erythrocyte membrane physical properties.

Authors:  U J Dumaswala; M J Wilson; T José; D L Daleke
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

3.  Measuring two-dimensional receptor-ligand binding kinetics by micropipette.

Authors:  S E Chesla; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

4.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

5.  Low-avidity recognition by CD4+ T cells directed to self-antigens.

Authors:  John A Gebe; Ben A Falk; Kellee A Rock; Sharon A Kochik; Anne K Heninger; Helena Reijonen; William W Kwok; Gerald T Nepom
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

6.  Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55.

Authors:  Mandy L Ford; Brian D Evavold
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

7.  Origin of regulatory T cells with known specificity for antigen.

Authors:  Irina Apostolou; Adelaida Sarukhan; Ludger Klein; Harald von Boehmer
Journal:  Nat Immunol       Date:  2002-07-01       Impact factor: 25.606

Review 8.  Heterogeneity in the clonal T cell response. Implications for models of T cell activation and cytokine phenotype development.

Authors:  C T Weaver; A Saparov; L A Kraus; W O Rogers; R D Hockett; R P Bucy
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

9.  CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

Authors:  Kristin V Tarbell; Sayuri Yamazaki; Kara Olson; Priscilla Toy; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

10.  In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.

Authors:  Qizhi Tang; Kammi J Henriksen; Mingying Bi; Erik B Finger; Greg Szot; Jianqin Ye; Emma L Masteller; Hugh McDevitt; Mark Bonyhadi; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  10 in total

1.  CD45RB Status of CD8+ T Cell Memory Defines T Cell Receptor Affinity and Persistence.

Authors:  Scott M Krummey; Anna B Morris; Jesica R Jacobs; Donald J McGuire; Satomi Ando; Katherine P Tong; Weiwen Zhang; Jennifer Robertson; Sara A Guasch; Koichi Araki; Christian P Larsen; Brian D Evavold; Haydn T Kissick; Mandy L Ford
Journal:  Cell Rep       Date:  2020-02-04       Impact factor: 9.423

2.  High self-reactivity drives T-bet and potentiates Treg function in tissue-specific autoimmunity.

Authors:  Maran L Sprouse; Marissa A Scavuzzo; Samuel Blum; Ivan Shevchenko; Thomas Lee; George Makedonas; Malgorzata Borowiak; Matthew L Bettini; Maria Bettini
Journal:  JCI Insight       Date:  2018-01-25

Review 3.  Development of T-cell tolerance utilizes both cell-autonomous and cooperative presentation of self-antigen.

Authors:  Justin S A Perry; Chyi-Song Hsieh
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

4.  A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery.

Authors:  Baoyu Liu; Jennifer D Hood; Elizabeth M Kolawole; Derek M Woodruff; Dario A Vignali; Maria Bettini; Brian D Evavold
Journal:  Diabetes       Date:  2019-12-05       Impact factor: 9.461

5.  CD4 T Cell Affinity Diversity Is Equally Maintained during Acute and Chronic Infection.

Authors:  Rakieb Andargachew; Ryan J Martinez; Elizabeth M Kolawole; Brian D Evavold
Journal:  J Immunol       Date:  2018-05-18       Impact factor: 5.422

6.  NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease.

Authors:  Lori Blanchfield; Joseph J Sabatino; Laurel Lawrence; Brian D Evavold
Journal:  J Immunol       Date:  2017-09-08       Impact factor: 5.422

7.  Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood.

Authors:  Katrin Klocke; Shimon Sakaguchi; Rikard Holmdahl; Kajsa Wing
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

8.  T Cell Receptor-Major Histocompatibility Complex Interaction Strength Defines Trafficking and CD103+ Memory Status of CD8 T Cells in the Brain.

Authors:  Anna Sanecka; Nagisa Yoshida; Elizabeth Motunrayo Kolawole; Harshil Patel; Brian D Evavold; Eva-Maria Frickel
Journal:  Front Immunol       Date:  2018-06-05       Impact factor: 7.561

9.  2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes.

Authors:  Elizabeth M Kolawole; Rakieb Andargachew; Baoyu Liu; Jesica R Jacobs; Brian D Evavold
Journal:  Front Immunol       Date:  2018-10-15       Impact factor: 7.561

Review 10.  Relationship of 2D Affinity to T Cell Functional Outcomes.

Authors:  Elizabeth M Kolawole; Tracey J Lamb; Brian D Evavold
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.